Prevention of hemolysis

Details Prevention of hemolysis Prevention of hemolysis

1994-11-30

1998-07-07

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514832, 514833, 514970, 536 46, 536 49, 536103, 424529, 424533, A61K 3170

Patent

active

057769141

ABSTRACT:
Disclosed are compositions and methods for preventing or substantially inhibiting the hemolytic activity of hemolysis inducing agents. The methods and compositions are based on the use of an anionic oligosaccharide, such as polysulfated cyclodextrin, to achieve the desired reduction in hemolytic active inducing agents.

REFERENCES:
patent: 3420788 (1969-01-01), Solms
patent: 4020160 (1977-04-01), Bernstein et al.
patent: 4066829 (1978-01-01), Nair et al.
patent: 4247535 (1981-01-01), Lewis et al.
patent: 4258180 (1981-03-01), Lewis et al.
patent: 4352794 (1982-10-01), Koch
patent: 4383992 (1983-05-01), Lipari
patent: 4582900 (1986-04-01), Branot et al.
patent: 4596795 (1986-06-01), Pitha
patent: 4703042 (1987-10-01), Bodor
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4834985 (1989-05-01), Elger et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4877774 (1989-10-01), Pitha et al.
patent: 4877778 (1989-10-01), Carpenter et al.
patent: 4902788 (1990-02-01), Zemel et al.
patent: 4983586 (1991-01-01), Bodor
patent: 5002935 (1991-03-01), Bodor
patent: 5008386 (1991-04-01), Szabo et al.
patent: 5017566 (1991-05-01), Bodor
patent: 5019562 (1991-05-01), Folkman
patent: 5024998 (1991-06-01), Bodor
patent: 5068226 (1991-11-01), Weinshenker et al.
patent: 5079002 (1992-01-01), Nagai et al.
patent: 5100878 (1992-03-01), Geber
patent: 5183809 (1993-02-01), Weisz et al.
K. Uekama et al., J. Pharma. Pharmacol., vol. 33, pp. 707-710 (1981).
W. Saenger, Angew. Chem. Int. Ed. Engl., vol 19, pp. 344-362.
K. Uekama et al., Chem. Pharm. Bull., vol. 37, pp. 76-80 (1979).
Y. Sato et al., Yakugazu Zasshi, vol. 102, pp. 874-880 (1982).
T. Irie et al., J. Pharm. Dyn., vol. 6, pp. 408-414 (1983).
K. Masuda et al., Yakugazu Zasshi, vol. 104, pp. 1075-1082 (1982).
T. Irie et al., J. Pharm. Dyn., vol. 5, pp. 741-744 (1982).
J. Follezoa et al., J. Biomed. Pharmacother., vol. 36, pp. 326-328 (1982).
I. Jodal et al., Proceedings of the Fourth International Symposium on Cyclodextrins, O. Huber and J. Szejthi, Eds., pp. 421-425, Kluwer Academic Publishers, Boston (1988).
Clay and Clay Minerals, vol. 34, pp. 74-80 (1986).
Nakashima et al, Antimicrobial Agents and Chemotherapy, pp. 1524-1528 (1987).
Uekama et al. International Journal of Pharmaceutics, vol. 10, pp. 1-15 (1982).
J. Pitha et al., Journal of Pharmaceutical Sciences, vol. 75(2), pp. 165-167 (1986).
Yamamoto et al., International Journal of Pharmaceutics, vol. 49, pp. 163-171 (1989).
Chemical Abstracts, 96:218351u (1982).
Croft et al., Tetrahedron, vol. 39, pp. 1417-1474 (1983).
Fenyuesi et al., Chem. Pharma. Bull., vol. 32(2), pp. 665-669 (1984).
Fenyuesi et al. Chem. Pharma. Bull., vol. 32(2), pp. 670-677(1984).
Komiyama et al., Polymer Journal, vol. 18(4), pp. 375-377 (1986).
Herrmann, H.C., Abstracts of Papers, National Meeting of the American Heart Association, Anaheim, CA; Nov. 11-14, 1991.
Chemical Abstracts 83:79544a (1975).
The Merck Index, Eleventh Edition, Susan Budavari et al. editor, Published by Merck & Co., Inc. Rahway, N.J., U.S.A., 1989, p. 256.
Alberts et al., "Molecular Biology of the Cell," Garland Publishing, Inc., N.Y., N.Y., 1983, pp. 702-709.
Young et al., J. Exp. Med. vol. 165, pp. 1371-1382, May 1987.

Affiliated with

Also associated with

Rating

Prevention of hemolysis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of hemolysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of hemolysis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1206010